Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets open firm
Mon, 11 Aug 09:30 am

Barring Malaysia (down 0.4%), most major Asian stock markets have opened the day in the green with stock markets in Japan (up 2.1%) and Hong Kong (up 1.2%) leading the gains. The Indian share markets have also opened the day on a positive note. Barring the FMCG index, all sectoral indices have opened in the green with realty and auto indices leading the gains.

The Sensex today is up by around 198 points (0.8%), while the NSE-Nifty is up by about 51 points (0.7%). Mid and small cap stocks are also trading in the green with the BSE Mid Cap and BSE Small Cap indices up by around 1.1% and 1.3% respectively. The rupee is currently trading at Rs 61.16 to the US dollar.

Engineering stocks have opened mainly in the green with Jyoti Structures Ltd and BGR Energy Ltd leading the gains. As per a leading financial daily, Larsen & Toubro (L&T) is planning to strengthen its project management team and to go in for subcontracting instead of hiring local staff in the Persian Gulf. It is to be noted that with domestic hydrocarbon business muted, the company has spread its operations in the Gulf and has been trying to get large orders in the segment for the last three years. The decision is in response to a loss of Rs 9.4 bn at the operating level in the hydrocarbon segment. The business has been impacted due to increase in wages in the Gulf region, changes in contract conditions, including mandatory hiring of locals, time and cost overruns and some delays from clients. Also, the company had to rework some of its projects to meet safety and quality standards in the region. The segment makes up around 7% of the company's order book.

Indian Pharma stocks have opened the day mainly in the green with J.B Chemicals and Aurobindo Pharma Ltd leading the gains. As per a leading financial daily, Sun Pharmaceutical Industries which is in the process of acquiring control of Ranbaxy Laboratories from Daiichi Sankyo, will aid Sun's growth in various ways as the company will be able to rationalize the research and development costs. Daichii's association with Ranbaxy will also help Sun to enter the Japanese market. One should note, the GMP norms in Japan market are very stringent and many generic companies have failed to establish themselves. Reportedly, the company's entry in Japan's markets is expected to take place three to four years after it closes its deal to acquire Ranbaxy and once basic issues at the company have been fixed. The deal worth US$4 bn is currently awaiting various regulatory clearances.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets open firm". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.